KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Inventory Average (2009 - 2026)

Johnson & Johnson recorded quarterly Inventory Average of $14.4 billion in Q1 2026, up 1.54% quarter-over-quarter from $14.2 billion in Q4 2025, and up 14.62% year-over-year from $12.6 billion in Q1 2025.

Johnson & Johnson's Inventory Average history runs 18 years deep, the most recent figure standing at $14.4 billion for Q1 2026.

  • In Q1 2026, Inventory Average rose 14.62% year-over-year to $14.4 billion; the TTM figure through Mar 2026 stood at $14.4 billion (up 14.62% YoY), while the FY2025 annual figure was $13.3 billion, up 12.74% from the prior year.
  • Inventory Average came in at $14.4 billion for Q1 2026 at Johnson & Johnson, up from $14.2 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $14.4 billion in Q1 2026 to a low of $10.4 billion in Q1 2022.
  • A 5-year average of $12.1 billion and a median of $11.9 billion in 2023 frame the typical range for Inventory Average.
  • Across the five-year window, Inventory Average dropped 8.35% in 2024 and climbed 14.62% in 2026, its largest moves.
  • Johnson & Johnson's Inventory Average stood at $11.6 billion in 2022, then declined by 3.17% to $11.2 billion in 2023, then rose by 11.92% to $12.5 billion in 2024, then rose by 13.14% to $14.2 billion in 2025, then advanced by 1.54% to $14.4 billion in 2026.
  • According to Business Quant data, Inventory Average over the past three periods registered $14.4 billion, $14.2 billion, and $13.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - 2.74 Bn
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 14.14 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 14.39 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 5.00 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 6.57 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 6.21 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 1.84 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 10.66 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 2.72 Bn
10 Gsk 88.34 Bn 83.66 Bn - 7.58 Bn

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 14.39 Bn
Dec 28, 2025 14.17 Bn
Sep 28, 2025 13.78 Bn
Jun 29, 2025 13.04 Bn
Mar 30, 2025 12.55 Bn
Dec 29, 2024 12.52 Bn
Sep 29, 2024 12.39 Bn
Jun 30, 2024 11.78 Bn
Mar 31, 2024 11.28 Bn
Dec 31, 2023 11.19 Bn
Oct 1, 2023 12.04 Bn
Jul 2, 2023 12.85 Bn
Apr 2, 2023 11.54 Bn
Jan 1, 2023 10.97 Bn
Oct 2, 2022 11.56 Bn
Jul 3, 2022 11.21 Bn
Apr 3, 2022 10.69 Bn
Jan 2, 2022 10.39 Bn
Oct 3, 2021 10.24 Bn
Jul 4, 2021 10.03 Bn
Apr 4, 2021 9.65 Bn
Jan 3, 2021 9.47 Bn
Sep 27, 2020 9.51 Bn
Jun 28, 2020 9.15 Bn
Mar 29, 2020 8.94 Bn
Dec 29, 2019 9.10 Bn
Sep 29, 2019 9.22 Bn
Jun 30, 2019 9.17 Bn
Mar 31, 2019 8.84 Bn
Dec 30, 2018 8.64 Bn
Sep 30, 2018 8.74 Bn
Jul 1, 2018 8.91 Bn
Apr 1, 2018 8.89 Bn
Dec 31, 2017 9.14 Bn
Oct 1, 2017 9.61 Bn
Jul 2, 2017 9.29 Bn
Apr 2, 2017 8.51 Bn
Jan 1, 2017 8.32 Bn
Oct 2, 2016 8.51 Bn
Jul 3, 2016 8.35 Bn
Apr 3, 2016 8.11 Bn
Jan 3, 2016 8.13 Bn
Sep 27, 2015 8.25 Bn
Jun 28, 2015 8.19 Bn
Mar 29, 2015 8.13 Bn
Dec 28, 2014 8.30 Bn
Sep 28, 2014 8.29 Bn
Jun 29, 2014 8.08 Bn
Mar 30, 2014 7.94 Bn
Dec 29, 2013 8.00 Bn
Sep 29, 2013 7.97 Bn
Jun 30, 2013 7.76 Bn
Mar 31, 2013 7.59 Bn
Dec 30, 2012 7.65 Bn
Sep 30, 2012 7.75 Bn
Jul 1, 2012 7.25 Bn
Apr 1, 2012 6.54 Bn
Jan 1, 2012 6.36 Bn
Oct 2, 2011 6.42 Bn
Jul 3, 2011 6.31 Bn
Apr 3, 2011 5.79 Bn
Jan 2, 2011 5.39 Bn
Oct 3, 2010 5.24 Bn
Jul 4, 2010 5.19 Bn
Apr 4, 2010 5.24 Bn
Jan 3, 2010 5.37 Bn
Sep 27, 2009 5.52 Bn